Micro Focus shareholders have overwhelmingly approved the British technology company’s acquisition of HP Enterprise’s software business, a deal that has propelled the Newbury-based group into the FTSE 100.
The approval for the $8.8bn deal comes only weeks after Micro Focus issued a damaging warning on its growth prospects because of a slowdown in sales at the former Hewlett-Packard assets. The investor meeting, held near St Pauls in London, was attended by only one shareholder.
Approval for the multibillion merger and a $500m return of cash to shareholders was passed without objection in less than 10 minutes.
The deal is the third-largest by a British company since the vote to leave the EU last summer, following the BAT-Reynolds buyout and Reckitt Benckiser’s agreed $18bn takeover of Mead Johnson.
Full Content: The Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas